BioMarin to Participate in Three Upcoming Virtual Investor Conferences
- Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 1:15pm ET
- BofA Global Healthcare Conference 2021 on September 17 at 12:35pm ET/5:35pm BST
- J.P. Morgan 12th Annual U.S. All Stars Conference on September 22 at 12:00pm ET/5:00pm BST
SAN RAFAEL, Calif., Aug. 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: |
|
Investors |
Media |
Traci McCarty |
Debra Charlesworth |
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
(415) 455-7558 |
(415) 455-7451 |
SOURCE BioMarin Pharmaceutical Inc.
![](https://rt.prnewswire.com/rt.gif?NewsItemId=SF85659&Transmission_Id=202108250830PR_NEWS_USPR_____SF85659&DateId=20210825)
Share this article